Cargando…
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Hepatocellular carcinoma (HCC) is a primary concern for patients with chronic hepatitis B (CHB). Antiviral therapy has been reasonably the focus of interest for HCC prevention, with most studies reporting on the role of the chronologically preceding agents, interferon-alfa and lamivudine. The impact...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association for the Study of the Liver
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066383/ https://www.ncbi.nlm.nih.gov/pubmed/27729632 http://dx.doi.org/10.3350/cmh.2016.0045 |